Tekrardan Hoşgeldiniz
Cointime’a Katıl
Giriş Yap
Kayıt Ol
Gelen kutunuzu kontrol edin
Noninvasix
About
Noninvasix is developing the first non-invasive technology for monitoring the oxygenation of veins.
- 1 - 10
Highlights
Details
- Last Funding Type
- Convertable Note
- Industries
- Health Care,Life Science,Medical Device
- Founded date
- Jan 1, 2007
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Noninvasix, Inc. (the “Company” or “Noninvasix”) is a medical technology company that has developed a novel solution to non-invasively monitor for the first time, oxygen sufficiency in organs and veins. The Company was founded in 2007 by Dr. Donald Prough and Dr. Rinat Esenaliev at the University of Texas Medical Branch (UTMB) and is based out of Houston, Texas. The Company has raised over $6.8 million to date including a seed round in Q4 2021. The platform technology of the Company has been developed with $6 million in grants from the NIH and DOD. The Company has also been a part of prestigious accelerator programs such as Philips Healthworks, TMCx, JLabs, Health Wildcatters and has won multiple awards for their innovation. The non-invasive technology has been clinically validated in multiple peer-reviewed journals. The IP portfolio of the Company includes 9 U.S. and 8 global patents.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 9, 2015 | Convertable Note | — | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Convertable Note |
